Back to results
US 6,582,689 B1Granted
IL-18/IGIF chemotherapeutic compositions
AssigneeSmithKline Beecham Corporation
InventorRandall K. Johnson
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to compositions comprising potentiators, such as IL-18, also known as interferon-γ-inducing factor (IGIF), in combination with a chemotherapeutic agent, processes for making such compositions, the use of such compositions for the prevention and/or treatment of cancer, and the use of such compositions to inhibit the growth of tumors or cancerous cells in mammals.
Claims5
A pharmaceutical composition comprising the polypeptide having the amino acid sequence of SEQ ID NO:1, in combination with topotecan.
Dependencies are inferred from the claim text.